<p>JERSEY CITY, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and
<p><strong>Overnight Headlines</strong></p> <p>*USD quiet over US holiday, steady near lows</p> <p>*US stocks were closed, European shares climbed to near rec
Leave a Comment